HelpMeSee has partnered with new initiatives to address the global cataract blindness crisis, focusing on empowering women in ...
In June 2024, a canalicular gel device (Lacrifill, Nordic Pharma) was introduced to the US market, and a recent study has ...
FDA clearance of HG202 marks a significant milestone for CRISPR/Cas13 RNA-editing in clinical applications for nAMD. The ...
A Johns Hopkins study reveals that anti-VEGF treatments for wet AMD may unintentionally elevate ANGPTL4, a protein that ...
Peking University researchers have developed a deep learning-based, noninvasive choroidal angiography method that enables ...
Atsena Therapeutics and Nippon Shinyaku have formed an exclusive licensing agreement for ATSN-101, a gene therapy for Leber ...
Vevye will be included in key formularies of major plan sponsors, covering over 25 million Medicare Part D beneficiaries ...
Pediatric cataract surgeries are more costly than adult procedures, with significant nonsurgical expenses like anesthesia and ...
Orbis customizes glaucoma training based on regional needs, offering basic to advanced surgical skills and early detection strategies. Cybersight platform facilitates remote mentoring, AI diagnostics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback